[{"indications": "Indications\u00a0local treatment of herpes simplex\r\ninfections", "name": "ACICLOVIR - ANTIVIRALS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "11 Eye", "11.3 Anti-infective eye preparations", "11.3.3 Antivirals", "ACICLOVIR"], "side-effects": "Side-effects\u00a0local irritation and inflammation, superficial\r\npunctate keratopathy; rarely blepharitis; very rarely hypersensitivity reactions including angioedema", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5413.htm", "doses": ["Apply 5 times daily (continue for at least 3 days after\r\ncomplete healing)"]}, {"indications": "Indications\u00a0\n(From 13.10.3 Antiviral preparations: British National Formulary)\n13.10.3 Antiviral preparations; herpes simplex and varicella\u2013zoster\r\ninfections (%s\n(From ACICLOVIR: British National Formulary)\nACICLOVIR); eye infections (%s\n(From ACICLOVIR: British National Formulary)\nACICLOVIR)", "name": "ACICLOVIR - ANTIVIRAL PREPARATIONS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.10 Anti-infective skin preparations", "13.10.3 Antiviral preparations"], "cautions": "Cautions\u00a0avoid contact with eyes and mucous membranes", "side-effects": "Side-effects\u00a0transient stinging or burning; occasionally erythema,\r\nitching or drying of the skin", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/6183.htm", "doses": ["Apply to lesions every 4 hours (5 times daily) for 5\u201310\r\ndays, starting at first sign of attack"], "pregnancy": "Pregnancy\u00a0not known to be harmful\u2014manufacturers advise use\r\nonly when potential benefit outweighs risk; limited absorption from\r\ntopical aciclovir preparations"}, {"indications": "Indications\u00a0\n(From 13.10.3 Antiviral preparations: British National Formulary)\n13.10.3 Antiviral preparations; herpes simplex and varicella\u2013zoster\r\ninfections (%s\n(From ACICLOVIR: British National Formulary)\nACICLOVIR); eye infections (%s\n(From ACICLOVIR: British National Formulary)\nACICLOVIR)", "name": "ACICLOVIR", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.10 Anti-infective skin preparations", "13.10.3 Antiviral preparations"], "cautions": "Cautions\u00a0avoid contact with eyes and mucous membranes", "side-effects": "Side-effects\u00a0transient stinging or burning; occasionally erythema,\r\nitching or drying of the skin", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/6183.htm", "doses": ["Apply to lesions every 4 hours (5 times daily) for 5\u201310\r\ndays, starting at first sign of attack"], "pregnancy": "Pregnancy\u00a0not known to be harmful\u2014manufacturers advise use\r\nonly when potential benefit outweighs risk; limited absorption from\r\ntopical aciclovir preparations"}, {"indications": "Indications\u00a0herpes simplex and varicella\u2013zoster (see also under Dose)", "name": "ACICLOVIR - HERPES SIMPLEX AND VARICELLA\u2013ZOSTER INFECTION", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.3 Antiviral drugs", "5.3.2 Herpesvirus infections", "5.3.2.1 Herpes simplex and varicella\u2013zoster infection"], "cautions": "Cautions\u00a0maintain adequate hydration (especially with infusion\r\nor high doses, or during renal impairment); elderly (risk of neurological reactions); interactions: Appendix 1 (aciclovir)", "side-effects": "Side-effects\u00a0nausea, vomiting, abdominal pain, diarrhoea, headache,\r\nfatigue, rash, urticaria, pruritus, photosensitivity; very\r\nrarely hepatitis, jaundice, dyspnoea, neurological reactions\r\n(including dizziness, confusion, hallucinations, convulsions, ataxia,\r\ndysarthria, and drowsiness), acute renal failure, anaemia, thrombocytopenia\r\nand leucopenia; on intravenous infusion, severe local\r\ninflammation (sometimes leading to ulceration), and very rarely agitation, tremors, psychosis and fever", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3994.htm", "doses": ["By mouth, non-genital herpes simplex,\r\ntreatment, 200\u00a0mg (400\u00a0mg in the immunocompromised or if absorption\r\nimpaired) 5 times daily, usually for 5 days (longer if new lesions\r\nappear during treatment or if healing incomplete); child 1 month\u20132 years, half adult dose, over 2 years,\r\nadult dose", "Genital herpes simplex, treatment of first episode, 200\u00a0mg 5 times daily or 400\u00a0mg 3 times daily usually\r\nfor 5 days, longer if new lesions appear during treatment or if healing\r\nis incomplete (400\u00a0mg 5 times daily for 7\u201310 days in immunocompromised\r\nor HIV-positive patients); treatment of recurrent infection, 800\u00a0mg 3 times daily for 2 days or 200\u00a0mg 5 times\r\ndaily for 5 days or 400\u00a0mg 3 times daily for 3\u20135\r\ndays (400\u00a0mg 3 times daily for 5\u201310 days in immunocompromised or HIV-positive\r\npatients)", "Herpes simplex, suppression, 400\u00a0mg twice daily or 200\u00a0mg 4 times daily; increased to 400\u00a0mg 3 times daily if recurrences\r\noccur on standard suppressive therapy or for suppression of genital\r\nherpes during late pregnancy (from 36 weeks gestation); therapy interrupted\r\nevery 6\u201312 months to reassess recurrence frequency\u2014consider restarting\r\nafter two or more recurrences", "Herpes simplex, prophylaxis in the immunocompromised, 200\u2013400\u00a0mg\r\n4 times daily; child 1 month\u20132 years,\r\nhalf adult dose, over 2 years, adult dose", "Varicella and herpes zoster, treatment, 800\u00a0mg 5 times daily\r\nfor 7 days (for herpes zoster in immunocompromised continue for 2\r\ndays after crusting of lesions); child, varicella, 1 month\u20132 years 200\u00a0mg 4 times daily for 5 days; 2\u20136\r\nyears 400\u00a0mg 4 times daily for 5 days; 6\u201312 years 800\u00a0mg 4 times daily\r\nfor 5 days", "Attenuation of chickenpox (if varicella\u2013zoster immunoglobulin\r\nnot indicated) [unlicensed use], adult and child 40\u00a0mg/kg daily in 4 divided\r\ndoses for 7 days starting 1 week after exposure", "By intravenous infusion, treatment\r\nof herpes simplex in the immunocompromised, severe initial genital\r\nherpes, and varicella\u2013zoster, 5\u00a0mg/kg every 8 hours usually for 5\r\ndays, doubled to 10\u00a0mg/kg every 8 hours in varicella\u2013zoster in the\r\nimmunocompromised and in simplex encephalitis (usually given for at\r\nleast 10 days in encephalitis, possibly for 14\u201321 days); prophylaxis\r\nof herpes simplex in the immunocompromised, 5\u00a0mg/kg every 8 hours", "To avoid excessive dosage in obese patients,\r\nparenteral dose should be calculated on the basis of ideal weight\r\nfor height", "neonate and infant up to 3 months, herpes simplex, 20\u00a0mg/kg every 8 hours for 14 days\r\n(21 days if CNS involvement); varicella\u2013zoster [unlicensed use] 10\u201320\u00a0mg/kg\r\nevery 8 hours for at least 7 days; child 3 months\u201312 years, herpes simplex or varicella\u2013zoster, 250\u00a0mg/m2 every 8 hours usually for 5 days, doubled to 500\u00a0mg/m2 every 8 hours for varicella\u2013zoster in the immunocompromised\r\nand in simplex encephalitis (usually given for at least 10 days in\r\nencephalitis, possibly for 14\u201321 days)", "By topical application, see section 13.10.3 (skin) and section 11.3.3 (eye)", "Aciclovir doses in BNF may differ from those\r\nin product literature"], "pregnancy": "Pregnancy\u00a0not known to be harmful\u2014manufacturers advise use\r\nonly when potential benefit outweighs risk"}]